TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
5,895
|
6,267
|
5,194 |
Financial expenses |
0
|
1
|
2 |
Earnings before taxes |
635
|
644
|
656 |
EBITDA |
635
|
649
|
664 |
Total assets |
2,245
|
2,593
|
2,366 |
Current assets |
2,020
|
2,363
|
2,110 |
Current liabilities |
651
|
1,082
|
862 |
Equity capital |
1,349
|
1,285
|
1,281 |
- share capital |
45
![]() |
45
|
49 |
Employees (average) |
6
|
5
![]() |
5 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
60.1%
|
49.6%
|
54.1% |
Turnover per employee |
982
|
1,253
|
1,039 |
Profit as a percentage of turnover |
10.8%
|
10.3%
|
12.6% |
Return on assets (ROA) |
28.3%
|
24.9%
|
27.8% |
Current ratio |
310.3%
|
218.4%
|
244.8% |
Return on equity (ROE) |
47.1%
|
50.1%
|
51.2% |
Change turnover |
-390
|
1,494
|
-497 |
Change turnover % |
-6%
|
31%
|
-9% |
Chg. No. of employees |
1
|
0
![]() |
0 |
Chg. No. of employees % |
20%
|
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.